166 related articles for article (PubMed ID: 33731738)
1. Assessment of clinical radiosensitivity in patients with head-neck squamous cell carcinoma from pre-treatment quantitative ultrasound radiomics.
Osapoetra LO; Dasgupta A; DiCenzo D; Fatima K; Quiaoit K; Saifuddin M; Karam I; Poon I; Husain Z; Tran WT; Sannachi L; Czarnota GJ
Sci Rep; 2021 Mar; 11(1):6117. PubMed ID: 33731738
[TBL] [Abstract][Full Text] [Related]
2. Quantitative ultrasound radiomics in predicting recurrence for patients with node-positive head-neck squamous cell carcinoma treated with radical radiotherapy.
Dasgupta A; Fatima K; DiCenzo D; Bhardwaj D; Quiaoit K; Saifuddin M; Karam I; Poon I; Husain Z; Tran WT; Sannachi L; Czarnota GJ
Cancer Med; 2021 Apr; 10(8):2579-2589. PubMed ID: 33314716
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound delta-radiomics during radiotherapy to predict recurrence in patients with head and neck squamous cell carcinoma.
Fatima K; Dasgupta A; DiCenzo D; Kolios C; Quiaoit K; Saifuddin M; Sandhu M; Bhardwaj D; Karam I; Poon I; Husain Z; Sannachi L; Czarnota GJ
Clin Transl Radiat Oncol; 2021 May; 28():62-70. PubMed ID: 33778174
[TBL] [Abstract][Full Text] [Related]
4. Quantitative US Delta Radiomics to Predict Radiation Response in Individuals with Head and Neck Squamous Cell Carcinoma.
Osapoetra LO; Dasgupta A; DiCenzo D; Fatima K; Quiaoit K; Saifuddin M; Karam I; Poon I; Husain Z; Tran WT; Sannachi L; Czarnota GJ
Radiol Imaging Cancer; 2024 Mar; 6(2):e230029. PubMed ID: 38391311
[TBL] [Abstract][Full Text] [Related]
5. A multi-objective radiomics model for the prediction of locoregional recurrence in head and neck squamous cell cancer.
Wang K; Zhou Z; Wang R; Chen L; Zhang Q; Sher D; Wang J
Med Phys; 2020 Oct; 47(10):5392-5400. PubMed ID: 32657426
[TBL] [Abstract][Full Text] [Related]
6. Application of contrast-enhanced CT radiomics in prediction of early recurrence of locally advanced oesophageal squamous cell carcinoma after trimodal therapy.
Tang S; Ou J; Liu J; Wu YP; Wu CQ; Chen TW; Zhang XM; Li R; Tang MJ; Yang LQ; Tan BG; Lu FL; Hu J
Cancer Imaging; 2021 May; 21(1):38. PubMed ID: 34039403
[TBL] [Abstract][Full Text] [Related]
7. Radiomics-based prediction of survival in patients with head and neck squamous cell carcinoma based on pre- and post-treatment
Liu Z; Cao Y; Diao W; Cheng Y; Jia Z; Peng X
Aging (Albany NY); 2020 Jul; 12(14):14593-14619. PubMed ID: 32674074
[TBL] [Abstract][Full Text] [Related]
8. Utility of adding Radiomics to clinical features in predicting the outcomes of radiotherapy for head and neck cancer using machine learning.
Gangil T; Sharan K; Rao BD; Palanisamy K; Chakrabarti B; Kadavigere R
PLoS One; 2022; 17(12):e0277168. PubMed ID: 36520945
[TBL] [Abstract][Full Text] [Related]
9. Predicting head and neck cancer treatment outcomes with pre-treatment quantitative ultrasound texture features and optimising machine learning classifiers with texture-of-texture features.
Safakish A; Sannachi L; DiCenzo D; Kolios C; Pejović-Milić A; Czarnota GJ
Front Oncol; 2023; 13():1258970. PubMed ID: 37849805
[TBL] [Abstract][Full Text] [Related]
10. Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.
Keek S; Sanduleanu S; Wesseling F; de Roest R; van den Brekel M; van der Heijden M; Vens C; Giuseppina C; Licitra L; Scheckenbach K; Vergeer M; Leemans CR; Brakenhoff RH; Nauta I; Cavalieri S; Woodruff HC; Poli T; Leijenaar R; Hoebers F; Lambin P
PLoS One; 2020; 15(5):e0232639. PubMed ID: 32442178
[TBL] [Abstract][Full Text] [Related]
11. Radiomics in predicting recurrence for patients with locally advanced breast cancer using quantitative ultrasound.
Dasgupta A; Bhardwaj D; DiCenzo D; Fatima K; Osapoetra LO; Quiaoit K; Saifuddin M; Brade S; Trudeau M; Gandhi S; Eisen A; Wright F; Look-Hong N; Sadeghi-Naini A; Curpen B; Kolios MC; Sannachi L; Czarnota GJ
Oncotarget; 2021 Dec; 12(25):2437-2448. PubMed ID: 34917262
[TBL] [Abstract][Full Text] [Related]
12. Quantitative ultrasound delta-radiomics during radiotherapy for monitoring treatment responses in head and neck malignancies.
Tran WT; Suraweera H; Quiaoit K; DiCenzo D; Fatima K; Jang D; Bhardwaj D; Kolios C; Karam I; Poon I; Sannachi L; Gangeh M; Sadeghi-Naini A; Dasgupta A; Czarnota GJ
Future Sci OA; 2020 Sep; 6(9):FSO624. PubMed ID: 33235811
[TBL] [Abstract][Full Text] [Related]
13. Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.
Elbers JBW; Al-Mamgani A; van den Brekel MWM; Jóźwiak K; de Boer JP; Lohuis PJFM; Willems SM; Verheij M; Zuur CL
Otolaryngol Head Neck Surg; 2019 Jun; 160(6):1023-1033. PubMed ID: 30526317
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients.
Alfieri S; Romanò R; Bologna M; Calareso G; Corino V; Mirabile A; Ferri A; Bellanti L; Poli T; Marcantoni A; Grosso E; Tarsitano A; Battaglia S; Blengio F; De Martino I; Valerini S; Vecchio S; Richetti A; Deantonio L; Martucci F; Grammatica A; Ravanelli M; Ibrahim T; Caruso D; Locati LD; Orlandi E; Bossi P; Mainardi L; Licitra LF
Acta Oncol; 2021 Sep; 60(9):1192-1200. PubMed ID: 34038324
[TBL] [Abstract][Full Text] [Related]
15. Early Changes in Quantitative Ultrasound Imaging Parameters during Neoadjuvant Chemotherapy to Predict Recurrence in Patients with Locally Advanced Breast Cancer.
Bhardwaj D; Dasgupta A; DiCenzo D; Brade S; Fatima K; Quiaoit K; Trudeau M; Gandhi S; Eisen A; Wright F; Look-Hong N; Curpen B; Sannachi L; Czarnota GJ
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267555
[TBL] [Abstract][Full Text] [Related]
16. Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma.
Bogowicz M; Riesterer O; Ikenberg K; Stieb S; Moch H; Studer G; Guckenberger M; Tanadini-Lang S
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):921-928. PubMed ID: 28807534
[TBL] [Abstract][Full Text] [Related]
17. Machine learning-based MRI texture analysis to predict occult lymph node metastasis in early-stage oral tongue squamous cell carcinoma.
Yuan Y; Ren J; Tao X
Eur Radiol; 2021 Sep; 31(9):6429-6437. PubMed ID: 33569617
[TBL] [Abstract][Full Text] [Related]
18. Biological predictors of radiosensitivity in head and neck squamous cell carcinoma.
Fiedler M; Weber F; Hautmann MG; Haubner F; Reichert TE; Klingelhöffer C; Schreml S; Meier JK; Hartmann A; Ettl T
Clin Oral Investig; 2018 Jan; 22(1):189-200. PubMed ID: 28315964
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
Huang SH; O'Sullivan B; Su J; Ringash J; Bratman SV; Kim J; Hosni A; Bayley A; Cho J; Giuliani M; Hope A; Spreafico A; Hansen AR; Siu LL; Gilbert R; Irish JC; Goldstein D; de Almeida J; Tong L; Xu W; Waldron J
Cancer; 2020 Aug; 126(15):3426-3437. PubMed ID: 32478895
[TBL] [Abstract][Full Text] [Related]
20. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
